Skip to content
Delayed ~15 min

KRRO KORRO BIO

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 17 analyst firms say about KORRO BIO: their latest ratings, price targets and how far the stock is from them. How it works

14.75 USD+0.02 (+0.14%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+33.7%to the avg target 19.71 USD+4.96 USD
Buy 15 · Hold 2 · Sell 0

17 rated views · 19 analyst/firm records · 17 firms

Latest report6 Oct 2026avg report date 13 Jun
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8046
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8052

Recent analyst activity · last 90 days

Our tracked history has 7 reports on KRRO from 6 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 3 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: RBC Capital raised its target from $8.00 (set 13 Nov 2025) to $10.00 on 31 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldSteve SeedhouseBuy28 Jan 2026Conflicting reports · excluded
Cantor FitzgeraldSteve SeehouseBuy13 Mar 202622.00 USD
Chardan Capital MarketsKeay T NakaeBuy8 May 202615.00 USD
CitigroupYigal NochomovitzBuy10 Sep 202621.00 USD
Clear StrUnnamed analystBuy18 Feb 2026—
Clear StreetUnnamed analystBuy19 Feb 202618.00 USD
Clear Street LLCKaveri PohlmanBuy1 May 202618.00 USD
H.C. WainwrightMitchell S. KapoorBuy6 Oct 202615.00 USD
JefferiesUnnamed analyst—6 Oct 202615.00 USD
JonestradingCatherine NovackBuy8 May 202623.00 USD
Lifesci CapitalThibaut R Pardo-GarciaBuy29 May 202621.00 USD
OppenheimerUnnamed analystBuy28 Jan 202622.00 USD
Piper SandlerYasmeen RahimiBuy5 Oct 202630.00 USD
Raymond JamesRyan DeschnerBuy7 Aug 202623.00 USD
Raymond JamesSteven SeedhouseBuy13 Mar 202623.00 USD
RBC Capital MarketsLuca IssiHold31 Aug 202610.00 USD
Weiss RatingsUnnamed analyst—2 Oct 2026—
William BlairMyles R MinterBuy6 Aug 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.